ANNX · Annexon, Inc.
$5.06
-0.01 (-0.20%)
At close · Aug 24
Market Cap
$1.04B
Shares
204.44M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$5.06
Open$5.05
Day$4.80–5.13
52W close$2.05–6.96
Avg vol 30d3.0M
Short int30.8M · 15.1% float · 10.5d
Short vol25%
Last earningsAug 12, 2026
DataJul 2020–Aug 2026
Filing10-Q · Aug 12
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 12, 2026
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Weak
Sentiment
Bullish
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 15.9 · calm
Equity put/call 0.68
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−4%
below
Price vs 50-day avg
−6%
below
RSI (14)
44
neutral
MACD trend
Negative
52-week position
61%
mid-range
Momentum
relative strength
1-month return
−1%
trailing
6-month return
−7%
trailing
YTD return
+1%
this year
Relative strength
−19%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $5 › 200d $5 — 50d above 200d
Institutional flow
Accumulating
+2% holders QoQ · +34 funds added
Insider flow
Accumulating
Net +$3.3M over 90 days · 0% sells
Short interest
Rising
15.05% of float · ▲ +3.2% MoM · 10.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
215 holders — near 3-yr high, broad support
Squeeze score
81
high risk · 0–100
Fundamentals
EPS growth
−33%
Y/Y
Free cash flow
$-186.5M
Balance sheet
$162.1M
net cash
Quant / Vol
risk profile
Volatility
78%
annualized · 1-yr
Max drawdown
−35%
past year
ATR
6.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−4%
Neutral
Price vs 50-day avg
−6%
Bearish
RSI (14)
44
Neutral
MACD trend
Negative
Bearish
52-week position
61%
Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $5 › 200d $5 — 50d above 200d
Institutional flow
Accumulating
+2% holders QoQ · +34 funds added
Insider flow
Accumulating
Net +$3.3M over 90 days · 0% sells
Short interest
Rising
15.05% of float · ▲ +3.2% MoM · 10.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
215 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $2
Now $5 · 61%
Range high $7
vs 200-day avg -4%
vs 50-day avg -6%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ANNX
this stock
Annexon, Inc.
|
$1.04B | +0.8% | — | — | 15.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$138.91B | +20.8% | +46.2% | 31.9 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$85.30B | +7.3% | +20.8% | 20.5 | 3.3% |
|
ARGX
Argenx SE
|
$64.66B | +20.2% | — | — | 2.1% |
|
CSLLY
Csl Ltd
|
$57.97B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ANNX | -1.4% | -1.4% | -6.8% | -0.7% | +0.8% |
| SPY | -1.2% | +3.3% | +12.2% | +2.2% | +12.0% |
| vs SPY | -0.2% | -4.7% | -19.0% | -2.9% | -11.2% |
Key facts
CIK
1528115
CUSIP
03589W102
13F (30d)
202 filings
195 filers
Visit website
Investor relations